View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Hematology/Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 18, 2024
3 min watch
Save

VIDEO: Improving immune checkpoint inhibitor use in EGFR-mutated lung cancer

VIDEO: Improving immune checkpoint inhibitor use in EGFR-mutated lung cancer

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights current challenges within the EGFR-mutated lung cancer space.

SPONSORED CONTENT
November 18, 2024
2 min watch
Save

VIDEO: Expert offers advice for residents seeing patients with EGFR-mutated lung cancer

VIDEO: Expert offers advice for residents seeing patients with <i>EGFR</i>-mutated lung cancer

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, offers advice to new residents seeing patients with EGFR-mutated lung cancer.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
November 18, 2024
3 min watch
Save

VIDEO: Monitoring for brain metastases key in patients with recurrent EGFR-mutated lung cancer

VIDEO: Monitoring for brain metastases key in patients with recurrent <i>EGFR</i>-mutated lung cancer

J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, spoke with Healio about monitoring patients with recurrent EGFR-mutated lung cancer.

SPONSORED CONTENT
November 18, 2024
3 min watch
Save

VIDEO: Collective understanding of biomarker testing important for EGFR-mutated lung cancer

VIDEO: Collective understanding of biomarker testing important for <i>EGFR</i>-mutated lung cancer

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights important takeaways for interventional pulmonologists and other providers who may see patients with EGFR-mutated lung cancer.

SPONSORED CONTENT
November 18, 2024
3 min watch
Save

VIDEO: Future use of antibody-drug conjugates in EGFR-mutated lung cancer

VIDEO: Future use of antibody-drug conjugates in <i>EGFR</i>-mutated lung cancer

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights potential treatments options coming to the EGFR-mutated lung cancer space.

SPONSORED CONTENT
November 18, 2024
6 min watch
Save

VIDEO: ‘Flurry of activity’ in treatment space for EGFR-mutated lung cancer

VIDEO: ‘Flurry of activity’ in treatment space for <i>EGFR</i>-mutated lung cancer

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, discusses the changing treatment landscape in EGFR-mutated lung cancer.

SPONSORED CONTENT
November 18, 2024
1 min read
Save

Laparoscopy may offer advantages to laparotomy for some women with ovarian cancer

Laparoscopy may offer advantages to laparotomy for some women with ovarian cancer

Laparoscopy may offer perioperative advantages to laparotomy and may be an acceptable alternative for some women with ovarian cancer, but systematic review and meta-analysis findings are limited by inclusion of only observational studies.

SPONSORED CONTENT
November 18, 2024
1 min read
Save

Immune checkpoint inhibitor therapy doubles psoriasis risk

Immune checkpoint inhibitor therapy doubles psoriasis risk

Patients with cancer who received immune checkpoint inhibitors exhibited increased risk for psoriasis compared with those treated with chemotherapy or targeted therapy.

SPONSORED CONTENT
November 16, 2024
1 min read
Save

Lung Cancer Awareness Month: Potential new standard in NSCLC, immunotherapy timing matters

Lung Cancer Awareness Month: Potential new standard in NSCLC, immunotherapy timing matters

Lung Cancer Awareness Month, observed every November, is intended to educate the public about the potential causes and risk factors of the disease.

SPONSORED CONTENT
November 15, 2024
2 min read
Save

‘Troubling’ data show lack of awareness about lung cancer screening

&lsquo;Troubling&rsquo; data show lack of awareness about lung cancer screening

Most people at high risk for lung cancer have not discussed screening for the disease with their clinician or have even heard of the test, according to a research letter published in JAMA Network Open.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails